Researchers from around the world will soon convene at the SITC Tumor Immune Microenvironment: A Holistic Approach to explore the latest breakthroughs in immunotherapy. PlatformQ Health is pleased to be presenting a poster at the event highlighting impressive outcomes from its recent CME program “Incorporating Checkpoint Inhibitors into Cancer Care: A study of the impact of digital education on clinical competence and practice patterns”.

With the emergence of immune checkpoint inhibitors, the clinical approach to diagnostic testing and treatment protocols have changed dramatically, leading to knowledge gaps. The digital education program was designed to improve core competencies in these areas. The program featured a panel discussion of medical specialists from The University of Texas MD Anderson Cancer Center, Vanderbilt-Ingram Cancer Center, as well as PlatformQ Health’s Medical Director.

More than 1,909 learners participated in the interactive sessions, which also featured in-session polling. The initiative succeeded in improving clinicians’ understanding of topics such as biomarker testing, combination therapies, checkpoint inhibitor use, adverse event management, and more. 74% of the learners reported that the activity positively impacted their clinical practice, and 61% reported the activity positively impacted patient experience and outcomes. 

Download the E-Poster here. 

Have questions about the posters or want to learn more about how PlatformQ Health is delivering impactful education to HCPs and patients? Email us at digital@platformq.com.